About
Partner with over three decades in neuroscience drug discovery. Founding scientist and Chief Scientific Officer at Sage Therapeutics, contributing to approved CNS drugs Zulresso and Zurzuvae, with prior roles at Lundbeck and Wyeth.
Experience
- Tortugas NeurosciencePresident and Head of Research and Developmentcurrent2026 β present
- Cure VenturesVenture Partner2026
- Cure VenturesPartner2024 β 2026Boston, Massachusetts, United States
- 73 R&D ConsultingScientist2023 β 2024United States
- Sage TherapeuticsChief Scientific Officer2011 β 2023Cambridge, MA
- Lundbeck Research, USAVice President2010 β 2011
- Wyeth pharmaceuticalsSenior Director; Head of Princeton Chemistry Dept2002 β 2010
- Bristol-Myers SquibbDirector2001 β 2002
- DuPont PharmaceuticalsDirector1999 β 2001
- DuPont Merck PharmaDirector1997 β 1999
- Merck PharmaResearch Fellow1991 β 1997
- FMCStaff Chemist1982 β 1984
Education
- Colorado State UniversityPost Doctoral Fellow, Organic Chemistry1989 β 1991
- UC IrvinePhD, Organic Chemistry1984 β 1989
- Rensselaer Polytechnic InstituteB.S., Chemistry1978 β 1982
Skills & more
Medicinal Chemistry90Lead Change25Organic Chemistry61Drug Discovery53Neuroscience53Biotechnology18Biochemistry4ADME2Clinical Development4Chemistry26Analytical Chemistry2Assay Development3
+3 more
Drug DesignDrug DevelopmentHPLCFrom Albert's professional profile.
Same school
Also attended Colorado State University27
Paul OsmundsonVice President Strategy & Innovation - ARUP Laboratories at EPIC VENTURESTim WeelborgGeneral Partner at Homegrown CapitalSamantha GuinnAnalyst at Novartis Venture FundAmy FullerExecutive Assistant at SQUADRA VENTURESJohn GearyHead of IT at Griffin Gaming PartnersTracy MarshbanksManaging Director at First Analysis
+ 21 more
Also attended UC Irvine74
Christian BuergerPortfolio Development at Intel CapitalJonathan GiegCommunity Manager at Pantera CapitalRyan LaurinManaging Director at Marlin Equity PartnersZack IsaacsonVenture Partner at Rackhouse Venture Management LpCameron BaharVenture Partner at Think+ Ventures Management, LlcTanya WesleyInvestor at TRANSFORMATION CAPITAL
+ 68 more
Also attended Rensselaer Polytechnic Institute56
Lawrence BettinoManaging Director at Dot CapitalPatch PaczkowskiVenture Partner at IronGate Capital AdvisorsJonathan BurbaumEntrepreneur-In-Residence at The Innovation SpaceElly KeinanVenture Partner at PitangoJoe LallouzInvestor at Ambush CapitalJeremiah BrazeauVenture Advisor at Underscore VC
+ 50 more
Shared employers
Also worked at Tortugas Neuroscience2
Also worked at Bristol-Myers Squibb45
Daniel LynchInvestor at GV (Google Ventures)Scott BillerInvestor at GV (Google Ventures)Avantika DaingFounding Partner at Plum Alley InvestmentsJake BauerVenture Partner at ARCH Venture PartnersBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersAdam ZongEntrepreneur-In-Residence at The Innovation Space
+ 39 more
Also worked at DuPont Pharmaceuticals2
Also worked at DuPont Merck Pharma32
John MayfieldPartner at Peak VenturesWilliam D. ProvinePresident & CEO at The Innovation SpaceTyler AmesEntrepreneur-In-Residence at The Innovation SpaceDeb TraversEntrepreneur-In-Residence at The Innovation SpaceAlexander KhutorskyVice President, Mergers & Acquisitions at DuPont at The Innovation SpaceCindy StewartAdvisor at Siddhi Capital
+ 26 more
Colleagues at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Bill Amsbaugh
CTO and Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
James Vath
Partner at Cure Ventures






















.png)















